Symbio Pharmaceuticals Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Symbio Pharmaceuticals Ltd with three other
companies in this sector in JAPAN :
Carna Biosciences Inc
sales of 3.21 billion Japanese Yen [US$30.79 million]
of which 66%
was Drug Discovery Business),
(2.07 billion Japanese Yen [US$19.92 million]
of which 100%
was Alliance), and
Japan Tissue Engineering Company Limited
(2.36 billion Japanese Yen [US$22.64 million]
of which 60%
was Regenerative Medicine Products Business).
Symbio Pharmaceuticals Ltd reported sales of ¥2.84 billion (US$27.24 million)
December of 2019.
decrease of 26.0%
versus 2018, when the company's sales were ¥3.84 billion.